Product Images Valsartan

This is a prescription drug called Valsartan that comes in the form of tablets. Mylan Pharmaceuticals Inc. is the manufacturer located in Morgantown, WY, USA. The drug should be kept out of the reach of children, stored at a temperature of 20° to 25°C (68° to 77°F), and protected from moisture. The dosage of the drug should be followed as per accompanying prescribing information. The details of the drug, such as its composition, indications, side effects, and warnings, are not available in the given text.*

Description: Valsartan is a medication available in the form of 80mg tablets, with NDC number 0378-5813-77. It is advised to check usually prescribed dosage before consuming. The tablets should be kept in a light-resistant container as defined in the USP (United States Pharmacopeia) and stored at a temperature between 20° to 25°C (68° to 77°F),protected from moisture. The medication should be kept out of reach of children. The code number for the drug is MH/DRUGS/25/NKD/89. The manufacturer of the medication is Mylan, and it comes in a package of 90 tablets. The expiration date of the medication is not available.*

This is a medication description for Valsartan, USP with a dosage of 160 mg. There are instructions for dosage and usage, as well as storage recommendations. The medication is produced by Wyan Pharmaceuticals and has a code number. The tablets are sold in containers that use child-resistant closures. Made in India.*

This is a description of the medication Valsartan, USP in a tablet form with a dosage of 320mg. The National Drug Code (NDC) is provided along with dosage information which can be found in the prescribing information. The medication should be stored at room temperature and protected from moisture while also being stored in a child-resistant container. The Mylan Pharmaceutical company, located in Morgantown, WY, USA, is responsible for the manufacturing of the medication, which is made in India.*

This appears to be a table showing different patient subgroups based on gender and ethnicity. It also includes information on the percentages of patients taking beta-blockers, as well as their preference for either Valsartan or Captopril as a medication.*